HIV/AIDS - PAHO/WHO | Pan American Health Organization
2024年9月30日 · ART reduces mortality and morbidity rates among HIV-infected people, and improves their quality of life. The benefits of ART also include the prevention of HIV transmission by suppressing HIV replication in persons living with the virus. This benefit of ART is also defined as “undetectable equal untransmittable” , or U=U.
HIV Drug Resistance - PAHO/WHO | Pan American Health …
2023年9月21日 · HIV drug resistance (HIVDR) is the ability of HIV to mutate and reproduce in the presence of antiretroviral (ARV) drugs. The consequences of drug resistance include treatment failure; the transmission of drug resistant HIV; as well as increased direct and indirect costs, for patients and health systems, due to more expensive, complex and toxic second- and third-line …
New HIV infections, deaths and persons living with HIV receiving ART in Latin America and the Caribbean ...
Guidelines for managing advanced HIV disease and rapid ... - PAHO
2017年7月7日 · Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
Concept note: Surveillance of HIV drug resistance in adults ... - PAHO
2014年7月7日 · HIV Drug Resistance emerges when HIV replicates in the presence of antiretroviral drugs. If HIV drug resistance becomes widespread, the drugs currently used to treat HIV infection may become ineffective. To date, levels of HIV Drug Resistance in countries scaling up ART remain manageable. However, resistance is slowly increasing: in East Africa, …
Updated recommendations on first-line and second-line ... - PAHO
2018年12月21日 · This web page provides interim guidance on first- and second-line antiretroviral regimens, post-exposure prophylaxis and early infant diagnosis of HIV. It updates the 2016 WHO guidelines with new evidence and experience on dolutegravir, raltegravir and virological testing.
PAHO highlights countries' progress, challenges in expanding …
2012年6月27日 · The series of fact sheets released this week provide data on the HIV epidemic in 32 countries and territories of the Americas. Details are provided on HIV prevalence, the percentage of HIV patients on ART, public spending on ART, HIV mortality, HIV-tuberculosis co-infections, and other key aspects of the epidemic.
Pre-Exposure Prophylaxis (PrEP) - PAHO/WHO | Pan American …
2023年12月5日 · PrEP is a HIV medication that reduces the risk of infection by over 90% for people at substantial risk. WHO guidelines recommend daily PrEP use and provide a tool for implementing PrEP programs in various settings and populations.
More developing countries show universal access to HIV/AIDS
2010年9月28日 · Global treatment coverage for HIV positive children was 28% in 2009, a notable progress, but the rate is lower than the ART coverage for adults (36%). And only 15% of children born to HIV-positive mothers were receiving appropriate infant diagnostics. "Every day, more than 1 000 infants acquire HIV during pregnancy, delivery and breastfeeding.
HIV epidemic and response in Latin America and the Caribbean
2022年10月27日 · Summary of HIV epidemic in the Americas, 2021. 27 Oct 2022. Communicable Diseases. HIV/AIDS.